AUA Capital Management’s Pfizer PFE Stock Holding History

AUA Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,337	Closed	-$240K	–	92
2023 Q4	$240K	Sell	8,337 -4,876	-37%	-$147K	0.15%	70
2023 Q3	$438K	Buy	13,213 +1,212	+10%	+$42.9K	0.32%	44
2023 Q2	$440K	Hold	12,001	–	–	0.3%	43
2023 Q1	$490K	Hold	12,001	–	–	0.33%	43
2022 Q4	$615K	Buy	12,001 +2,666	+29%	+$128K	0.42%	36
2022 Q3	$408K	Sell	9,335 -1,512	-14%	-$73.5K	0.27%	45
2022 Q2	$569K	Hold	10,847	–	–	0.33%	42
2022 Q1	$562K	Buy	10,847 +471	+5%	+$24.4K	0.3%	42
2021 Q4	$613K	Buy	10,376 +4,876	+89%	+$242K	0.36%	37
2021 Q3	$237K	Sell	5,500 -1,800	-25%	-$79.7K	0.15%	72
2021 Q2	$286K	Hold	7,300	–	–	0.18%	67
2021 Q1	$264K	Hold	7,300	–	–	0.17%	66
2020 Q4	$269K	Sell	7,300 -394	-5%	-$14.5K	0.19%	60
2020 Q3	$268K	Buy	7,694 +2,213	+40%	+$77.6K	0.22%	53
2020 Q2	$170K	Sell	5,481 -2,213	-29%	-$75.2K	0.17%	63
2020 Q1	$239K	Hold	7,694	–	–	0.23%	52
2019 Q4	$286K	Hold	7,694	–	–	0.24%	54
2019 Q3	$262K	Hold	7,694	–	–	0.21%	61
2019 Q2	$316K	Hold	7,694	–	–	0.25%	52
2019 Q1	$310K	Hold	7,694	–	–	0.26%	53
2018 Q4	$319K	Hold	7,694	–	–	0.29%	41
2018 Q3	$322K	Hold	7,694	–	–	0.25%	52
2018 Q2	$265K	Hold	7,694	–	–	0.23%	57
2018 Q1	$260K	Sell	7,694 -448	-6%	-$15.4K	0.22%	59
2017 Q4	$280K	Hold	8,142	–	–	0.25%	55
2017 Q3	$276K	Hold	8,142	–	–	0.25%	53
2017 Q2	$259K	Buy	8,142 +4,954	+155%	+$156K	0.23%	53
2017 Q1	$103K	Sell	3,188 -5,481	-63%	-$173K	0.1%	63
2016 Q4	$267K	Buy	+8,669	New	+$265K	0.26%	45

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AUA Capital Management's PFE Position: Q1 2024 in Review

AUA Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 8,337 shares — an estimated $240K sold.

AUA Capital Management first reported a position in PFE in Q4 2016 and held it in 29 quarters. The position peaked at $615K in Q4 2022. 2,882 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

AUA Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
AUA Capital Management sold 8,337 Pfizer shares in Q1 2024, an estimated $240K.
AUA Capital Management first reported a position in Pfizer in Q4 2016 and held it in 29 quarters.
AUA Capital Management's Pfizer position peaked at $615K in Q4 2022.
2,882 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on AUA Capital Management's 13F filing for Q1 2024, filed 11 Apr 2024.